Market: KLS |
Currency:
Address:
๐ M&A Historical Chart
๐ Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
No dividend history available.
๐
Earnings & EPS History for M&A
No earnings history available for this symbol.
๐ฐ Related News & Research
-
Shenzhen Woer Heat-Shrinkable Material Co., Ltd. (9981) Announces HKEX IPO Allotment Results, Final Offer Price, Cornerstone Investors & Listing Details
February 14, 2026
Shenzhen Woer Heat-Shrinkable Material Co., Ltd. IPO Analysis: Comprehensive Investor Guide Shenzhen Woer Heat-Shrinkable Material Co., Ltd. Date of Prospectus: February 5, 2026 Bold Move:…
-
Sichuan Biokin Pharmaceutical (688506) Hong Kong IPO: Innovative Oncology Pipeline, Global Strategy & Key Risk Factors Explained
February 14, 2026
Baili Pharmaceutical IPO Analysis: Growth, Strategy & Outlook for Investors Company Name: Baili Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Baili Pharmaceutical IPO:…
-
Sichuan Biokin Pharmaceutical (2615 HK) IPO: Global Offering Details, Application Process & Key Dates 2025
February 14, 2026
Sichuan Biokin Pharmaceutical Co., Ltd. IPO Analysis: Key Insights for Investors Sichuan Biokin Pharmaceutical Co., Ltd. Date of Prospectus: November 7, 2025 Sichuan Biokin Pharmaceutical:…
-
CASA Holdings Limited 2026 AGM Minutes: Resolutions, Financial Performance, and Strategic Updates
February 14, 2026
Casa Holdings Limited: 2026 AGM Review โ Key Developments and Investor Insights Casa Holdings Limited held its Annual General Meeting (AGM) on 23 January 2026…
-
Amplefield Limited 2026 AGM Minutes โ Resolutions, Directorsโ Re-Elections, Share Buyback Mandate and Shareholdersโ Q&A
February 13, 2026
Amplefield Limited AGM 2026: Key Decisions and Business Updates for Investors Amplefield Limited held its Annual General Meeting (AGM) on 28 January 2026 at RELC…
-
ThaiBev Q1 2026 Results: Higher EBITDA Despite Lower Sales, Spirits & Beer Margins Improve
February 13, 2026
ThaiBev 1Q26 Business Update: Key Financials, Segment Review, and Shareholder Insights ThaiBev Reports 1Q26 Business Update: EBITDA Growth Despite Revenue Headwinds Summary of Key Developments…
-
Bromat Holdings Ltd. Q1 2026 Financial Results: No Dividend Declared Amid Ongoing Losses and Business Restructuring
February 13, 2026
Bromat Holdings Ltd. Q1 FY2026 Financial Analysis: Performance, Trends, and Outlook Bromat Holdings Ltd. (formerly No Signboard Holdings Ltd.), a Singapore-based F&B operator, has released…
-
Singapore Institute of Advanced Medicine Holdings Ltd. 1H FY2026 Results: Financial Performance, No Dividend Declared
February 13, 2026
Singapore Institute of Advanced Medicine Holdings Ltd. โ 1H FY2026 Financial Analysis The Singapore Institute of Advanced Medicine Holdings Ltd. (“SIAM”) released its unaudited condensed…
-
OTS Holdings Limited 1H2026 Financial Results: Revenue Decline, No Dividend Declared, and Business Performance Review
February 13, 2026
OTS Holdings Limited: 1H2026 Financial Results Analysis OTS Holdings Limited, a Singapore-based manufacturer and trader of halal and non-halal meat products, released its condensed interim…
-
International Cement Group Ltd. Expects Significant Profit Growth for FY2025 Driven by Strong Demand and New Kazakhstan Plant; No Dividend Details Announced 1
February 13, 2026
International Cement Group Ltd. FY2025 Positive Profit Guidance: Financial Analysis and Investor Insights International Cement Group Ltd. (“the Company”) recently issued a positive profit guidance…
๐ View more Reports